REGENXBIO Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from REGENXBIO Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Description

Event date

Documents and forms

2025

Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 8, 2025

Transcript

Q2 2025

Aug 7, 2025

Transcript

Quarterly report10-Q

Earnings release8-K

Status Update

Jun 5, 2025

Slides

Press release

Q1 2025

May 12, 2025

Transcript

Quarterly report10-Q

Earnings release8-K

2024

Q4 2024

Mar 13, 2025

Transcript

Annual report10-K

Earnings release8-K

Q3 2024

Nov 6, 2024

Quarterly report10-Q

Earnings release8-K

Q2 2024

Aug 1, 2024

Quarterly report10-Q

Earnings release8-K

Q1 2024

May 8, 2024

Quarterly report10-Q

Earnings release8-K

Study Update

Mar 5, 2024

Slides

Press release

Study Update

Feb 7, 2024

Slides

Press release

Study Update

Jan 16, 2024

Press release

Slides

2023

Q4 2023

Feb 27, 2024

Annual report10-K

Earnings release8-K

Q3 2023

Nov 8, 2023

Quarterly report10-Q

Earnings release8-K

Study Update

Nov 6, 2023

Press release

Study Update

Oct 3, 2023

Press release

Q2 2023

Aug 2, 2023

Quarterly report10-Q

Earnings release8-K

Investor Day 2023

Jul 11, 2023

Slides

Press release

Q1 2023

May 3, 2023

Quarterly report10-Q

Earnings release8-K

2022

Q4 2022

Feb 28, 2023

Earnings release8-K

Annual report10-K

Q3 2022

Nov 3, 2022

Quarterly report10-Q

2021

Q4 2021

Mar 1, 2022

Annual report10-K

2020

Q4 2020

Mar 1, 2021

Annual report10-K

2019

Q4 2019

Feb 26, 2020

Annual report10-K

2018

Q4 2018

Feb 27, 2019

Annual report10-K

2017

Q4 2017

Mar 6, 2018

Annual report10-K

2016

Q4 2016

Mar 7, 2017

Annual report10-K

2015

Q4 2015

Mar 3, 2016

Annual report10-K